HP
TNGX icon

HealthInvest Partners’s Tango Therapeutics TNGX Stock Holding History

HealthInvest Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21M Buy
198,557
+168,642
+564% +$4.17M 1.67% 27
2026
Q1 		$3.63M Buy
+29,915
New +$416K 1.17% 31

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

HealthInvest Partners's TNGX Position: Q2 2026 in Review

HealthInvest Partners increased its Tango Therapeutics (TNGX) stake by 564% in Q2 2026, buying an estimated $4.17M and bringing the position to 198,557 shares worth $6.21M. The position accounts for 1.67% of the portfolio, ranked #27.

HealthInvest Partners first reported a position in TNGX in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • HealthInvest Partners held 198,557 shares of Tango Therapeutics worth $6.21M as of Q2 2026.
  • HealthInvest Partners bought 168,642 Tango Therapeutics shares in Q2 2026, an estimated $4.17M.
  • Tango Therapeutics made up 1.67% of HealthInvest Partners's portfolio in Q2 2026, its #27 holding.
  • HealthInvest Partners first reported a position in Tango Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.